<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://timesreporterafrica.com/article/905580232-sudan-reaffirms-neutrality-rejects-alignment-with-iran-in-conflicts-involving-the-united-states-and-israel</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T08:40:19+00:00</news:publication_date>
        <news:title>Sudan Reaffirms Neutrality, Rejects Alignment with Iran in Conflicts Involving the United States and Israel</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832058-general-intelligence-services-508x710.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905569411-south-africa-s-leading-business-plan-consultants-deliver-3-000-investor-ready-plans</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T08:07:47+00:00</news:publication_date>
        <news:title>South Africa&#39;s Leading Business Plan Consultants Deliver 3,000+ Investor-Ready Plans</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831947-jtb-consulting-3-000-busines-2752x1536.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905536204-tribuna-com-pr-sente-15-fonctionnalit-s-qui-red-finissent-les-possibilit-s-d-une-application-football</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T21:52:19+00:00</news:publication_date>
        <news:title>Tribuna.com Présente 15 Fonctionnalités qui Redéfinissent les Possibilités d&#39;une Application Football</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831795-tribuna-football-xtra-french-ce-2000x1200.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905647186-nxera-pharma-s-quviviq-daridorexant-25mg-and-50mg-receives-approval-in-taiwan-for-the-treatment-of-insomnia</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T08:42:59+00:00</news:publication_date>
        <news:title>Nxera Pharma’s QUVIVIQ® (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905636102-mestag-therapeutics-selected-to-present-targeted-ltbr-agonist-mst-0312-in-late-breaking-session-at-aacr-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-14T07:30:00+00:00</news:publication_date>
        <news:title>Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/d47c1200-a3a8-42b0-b0b9-ffb74568b42c/small/mestag-tx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905465297-mabel-mobile-massage-expands-fleet-for-mobile-massage-in-cape-town-with-two-new-vehicles</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T15:18:01+00:00</news:publication_date>
        <news:title>Mabel Mobile Massage Expands Fleet For Mobile Massage In Cape Town With Two New Vehicles</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831228-mobile-massage-beds-1360x1020.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905409315-strategic-microsoft-ecosystem-partnerships-are-the-defining-leadership-imperative-in-the-ai-era</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T14:04:02+00:00</news:publication_date>
        <news:title>Strategic Microsoft Ecosystem Partnerships Are the Defining Leadership Imperative in the AI Era</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830995-chamco-digital-strategic-micros-1000x600.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/904984928-applications-open-for-dnda26-awards-celebrating-humanity-centered-design-for-societal-impact-and-global-well-being</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>Applications Open for DNDA26 Awards: Celebrating Humanity-Centered Design for Societal Impact and Global Well-Being</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830562-dnda25-laureates-3240x2160.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905557487-aura-minerals-announces-update-to-capex-guidance-including-construction-of-the-era-dorada-project</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T22:55:16+00:00</news:publication_date>
        <news:title>Aura Minerals Announces Update to CAPEX Guidance Including Construction of the Era Dorada Project</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8cf4d71-4490-4f76-9508-65c56d8db7b4/small/logo-aura-360-mining-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905557380-aura-announces-full-board-approval-for-the-development-of-the-era-dorada-project-reinforcing-its-commitment-to-dialogue-transparency-and</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T22:33:24+00:00</news:publication_date>
        <news:title>Aura Announces Full Board Approval for the Development of the Era Dorada Project, Reinforcing Its Commitment to Dialogue, Transparency, and Responsible Mining</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8cf4d71-4490-4f76-9508-65c56d8db7b4/small/logo-aura-360-mining-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905549588-aim-immunotech-provides-routine-update-on-annual-filings</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T22:00:00+00:00</news:publication_date>
        <news:title>AIM ImmunoTech Provides Routine Update on Annual Filings</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905542317-emerita-confirms-receipt-of-unsolicited-offer-letter-from-denarius-metals</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T21:00:00+00:00</news:publication_date>
        <news:title>Emerita Confirms Receipt of Unsolicited Offer Letter from Denarius Metals</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7a6d9b24-d89a-4296-a342-37864cd19eba/small/emertia-verde-sinfondo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905542434-xortx-announces-closing-of-acquisition-of-vectus-kidney-anti-fibrotic-asset</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T21:00:00+00:00</news:publication_date>
        <news:title>XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9898c4f8-b373-438a-abfa-709c4372a061/small/xortx-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905446990-outsourced-cfo-to-participate-in-african-incubator-value-creation-series</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T08:43:22+00:00</news:publication_date>
        <news:title>Outsourced CFO to Participate in African Incubator Value Creation Series</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831147-group-of-people-standing-around-1500x1000.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905535401-bioage-labs-to-present-at-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:30:00+00:00</news:publication_date>
        <news:title>BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905535572-cema-cel-pivotal-trial-interim-data-highlight-strength-of-cellectis-allogeneic-car-t-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:30:00+00:00</news:publication_date>
        <news:title>Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905535574-les-donn-es-interm-diaires-de-l-essai-pivot-testant-cema-cel-mettent-en-vidence-la-solidit-de-la-plateforme-car-t-allog-nique-de-cellectis</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:30:00+00:00</news:publication_date>
        <news:title>Les données intermédiaires de l&#39;essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905535321-sana-biotechnology-and-mayo-clinic-announce-strategic-collaboration-focused-on-improving-care-in-type-1-diabetes-and-accelerating-development-of-sc451</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:05:00+00:00</news:publication_date>
        <news:title>Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2e5b81be-ddf0-4a60-85f1-3f17c242e8c2/small/sana-biotechnology-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905535390-celldex-to-present-at-upcoming-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:01:00+00:00</news:publication_date>
        <news:title>Celldex to Present at Upcoming Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905535566-revolution-medicines-inc-announces-proposed-offerings-of-common-stock-and-convertible-senior-notes</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:01:00+00:00</news:publication_date>
        <news:title>Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905535570-allogene-therapeutics-announces-proposed-public-offering-of-175-million-of-common-stock</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T20:01:00+00:00</news:publication_date>
        <news:title>Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905415185-ai-workforce-enablement-emerges-as-a-strategic-imperative-in-the-enterprise-ai-era</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T05:44:51+00:00</news:publication_date>
        <news:title>AI Workforce Enablement Emerges as a Strategic Imperative in the Enterprise AI Era</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831008-ai-workforce-enablement-image-1000x600.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/904680737-fmuser-announces-hardware-based-iptv-system-for-isps-in-the-middle-east-and-africa</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T05:32:29+00:00</news:publication_date>
        <news:title>FMUSER Announces Hardware-Based IPTV System for ISPs in the Middle East and Africa</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830707-1-1920x1080.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905495961-lahontan-reports-cyanide-recoveries-of-81-for-gold-and-60-for-silver-at-west-santa-fe</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T14:56:08+00:00</news:publication_date>
        <news:title>Lahontan Reports Cyanide Recoveries of 81% for Gold and 60% for Silver at West Santa Fe</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c092d23b-1acd-421c-88c7-de8b47eb2177/medium/average-au-recoveries-81.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905478602-optum-united-healthcare-united-behavioral-health-expands-neurostar-tms-coverage-to-include-psychiatric-mental-health-nurse-practitioners</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:32:00+00:00</news:publication_date>
        <news:title>Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905478464-alx-oncology-appoints-jeff-knight-as-chief-development-and-operating-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:30:00+00:00</news:publication_date>
        <news:title>ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905474988-septerna-announces-initiation-of-phase-1-clinical-trial-of-sep-479-an-oral-small-molecule-pth1r-agonist-for-the-treatment-of-hypoparathyroidism</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8c635733-2794-456f-9bc4-3b53908acba9/small/septernalogo-black-10x-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905474993-global-uranium-corp-announces-completion-of-geological-mapping-at-the-airline-project-in-wyoming</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Global Uranium Corp. Announces Completion of Geological Mapping at the Airline Project in Wyoming</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee2655b6-8532-431c-8045-cc4c311681ae/medium/figure-1.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905475004-favorable-results-of-ovarian-cancer-study-presented-at-annual-society-of-gynecological-care-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7e828ef4-6c8f-4c94-b376-4e3749530fba/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905475009-praxis-to-showcase-essential3-the-first-positive-phase-3-program-in-essential-tremor-at-aan-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905475045-daraxonrasib-demonstrates-unprecedented-overall-survival-benefit-in-pivotal-phase-3-rasolute-302-clinical-trial-in-patients-with-metastatic-pancreatic</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T12:00:00+00:00</news:publication_date>
        <news:title>Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905474987-nervgen-pharma-to-participate-in-the-h-c-wainwright-hcw-home-series-and-the-2026-bloom-burton-co-healthcare-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:45:00+00:00</news:publication_date>
        <news:title>NervGen Pharma to Participate in the H.C. Wainwright &quot;HCW@Home&quot; Series and the 2026 Bloom Burton &amp; Co. Healthcare Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905470696-deep-sea-minerals-corp-appoints-dan-mcconnell-as-vice-president-of-exploration</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:30:00+00:00</news:publication_date>
        <news:title>DEEP SEA MINERALS CORP. APPOINTS DAN MCCONNELL AS VICE PRESIDENT OF EXPLORATION</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/811181eb-f1f6-4baf-9d4e-783d1d472b55/small/deep-sea-logo-jan2026-jpg-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905470717-allogene-therapeutics-reports-interim-futility-analysis-from-pivotal-alpha3-trial-showing-58-3-mrd-clearance-with-cemacabtagene-ansegedleucel</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:30:00+00:00</news:publication_date>
        <news:title>Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905470743-fredonia-mining-inc-grants-stock-options-and-formalizes-management-agreements</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:30:00+00:00</news:publication_date>
        <news:title>Fredonia Mining Inc. Grants Stock Options and Formalizes Management Agreements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a2c40d42-717c-4ff9-9856-afe582a0f392/small/fredonia-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905470793-gelatide-drops-investigated-2026-report-what-consumers-should-verify-before-buying</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:23:50+00:00</news:publication_date>
        <news:title>Gelatide Drops Investigated (2026 Report) What Consumers Should Verify Before Buying</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/984a2986-fdd3-4fe6-80f2-312f9d1cbc94/image2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905466795-eclipse-life-sciences-completes-enrollment-in-phase-2-study-evaluating-ec-104-for-diabetic-macular-edema-dme</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>Eclipse Life Sciences Completes Enrollment in Phase 2 Study Evaluating EC-104 for Diabetic Macular Edema (DME)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3ed9dd28-ed00-4f7d-b5b9-1180c2c99262/small/eclipse-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905466986-ocular-therapeutix-announces-additional-positive-week-52-data-from-landmark-sol-1-phase-3-trial-of-axpaxli-in-wet-amd</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T11:00:00+00:00</news:publication_date>
        <news:title>Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905466998-gfg-exercises-its-option-and-earns-100-in-the-6-500-hectare-wwcc-property-in-the-prolific-timmins-gold-district</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T10:50:00+00:00</news:publication_date>
        <news:title>GFG Exercises its Option and Earns 100% in the 6,500-Hectare WWCC Property in the Prolific Timmins Gold District</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b9b9e049-6bf9-4789-bd45-659aff312d7b/medium/figure-1-regional-map-of-gfg-gold-projects-in-the-timmins-go.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905467025-leanzene-gummies-examined-2026-consumer-focused-breakdown-of-ingredients-claims-label-transparency</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T10:47:40+00:00</news:publication_date>
        <news:title>Leanzene Gummies Examined: 2026 Consumer-Focused Breakdown of Ingredients, Claims &amp; Label Transparency</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/e7b8402e-d943-467a-8865-1fec7f5629cc/image2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905463067-a-i-s-resources-engages-geo-data-solutions-gds-inc-to-complete-a-high-resolution-helicopter-borne-magnetic-survey-to-support-exploration-across-its</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T10:30:00+00:00</news:publication_date>
        <news:title>A.I.S. Resources engages Geo Data Solutions GDS Inc. to complete a high-resolution helicopter-borne magnetic survey to support exploration across its St. John Project</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/66594a75-4949-430b-9954-d9e7e29a5778/small/aislogo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905463143-telix-and-regeneron-announce-strategic-radiopharma-collaboration</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T10:30:00+00:00</news:publication_date>
        <news:title>Telix and Regeneron Announce Strategic Radiopharma Collaboration</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905459678-mexc-doubles-market-share-to-9-in-two-years-coingecko-reports</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-13T10:00:00+00:00</news:publication_date>
        <news:title>MEXC Doubles Market Share to 9% in Two Years, CoinGecko Reports</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e03bb1f5-f602-49a7-8ab8-5ffdea5088da/medium/mexc-doubles-market-share-to-9-in-two-years-coingecko-report.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://timesreporterafrica.com/article/905385512-nxera-pharma-s-partner-neurocrine-biosciences-doses-first-patient-in-phase-2-trial-of-nbi-1117570-for-adults-with-schizophrenia</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-12T23:30:00+00:00</news:publication_date>
        <news:title>Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png</image:loc>
        </image:image>
    </url>
</urlset>
